Recombinant multi-species ELA1/CELA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ELA1/CELA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Unlike other elastases, pancreatic elastase 1 is not expressed in the pancreas. To date, elastase 1 expression has only been detected in skin keratinocytes. Clinical literature that describes human elastase 1 activity in the pancreas or fecal material is actually referring to chymotrypsin-like elastase family, member 3B. [provided by RefSeq, May 2009]
The Alternative Names of target: ELA1, CELA1,Chymotrypsin-like elastase family member 1,Elastase-1, Pancreatic elastase 1,ELA1
Go
to ELA1/CELA1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T22839-Ab-1/ GM-Tg-hg-T22839-Ab-2 | Human ELA1/CELA1 protein | Human |
GM-Tg-rg-T22839-Ab-1/ GM-Tg-rg-T22839-Ab-2 | Rat ELA1/CELA1 protein | Rat |
GM-Tg-mg-T22839-Ab-1/ GM-Tg-mg-T22839-Ab-2 | Mouse ELA1/CELA1 protein | Mouse |
GM-Tg-cynog-T22839-Ab-1/ GM-Tg-cynog-T22839-Ab-2 | Cynomolgus/Rhesus macaque ELA1/CELA1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T22839-Ab-1/ GM-Tg-felg-T22839-Ab-2 | Feline ELA1/CELA1 protein | Feline |
GM-Tg-cang-T22839-Ab-1/ GM-Tg-cang-T22839-Ab-2 | Canine ELA1/CELA1 protein | Canine |
GM-Tg-bovg-T22839-Ab-1/ GM-Tg-bovg-T22839-Ab-2 | Bovine ELA1/CELA1 protein | Bovine |
GM-Tg-equg-T22839-Ab-1/ GM-Tg-equg-T22839-Ab-2 | Equine ELA1/CELA1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T22839-Ab-1/ GM-Tg-hg-T22839-Ab-2;
GM-Tg-rg-T22839-Ab-1/ GM-Tg-rg-T22839-Ab-2;
GM-Tg-mg-T22839-Ab-1/ GM-Tg-mg-T22839-Ab-2; GM-Tg-cynog-T22839-Ab-1/ GM-Tg-cynog-T22839-Ab-2; GM-Tg-felg-T22839-Ab-1/ GM-Tg-felg-T22839-Ab-2; GM-Tg-cang-T22839-Ab-1/ GM-Tg-cang-T22839-Ab-2; GM-Tg-bovg-T22839-Ab-1/ GM-Tg-bovg-T22839-Ab-2; GM-Tg-equg-T22839-Ab-1/ GM-Tg-equg-T22839-Ab-2 |
Products Name | ELA1/CELA1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | ELA1/CELA1 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ELA1/CELA1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.